Rejuran Healer vs. Sculptra vs. Juvelook: A Sourcing Guide for Clinics

Before examining the specific differences, this table provides a high-level overview for clinics sourcing these popular biostimulators.

The fundamental difference between these products lies in their active ingredients and how they interact with dermal tissue.

Rejuran Healer is based on Polynucleotides (PN), which are long-chain DNA fragments derived from salmon. Its mechanism is primarily regenerative. PN molecules provide a structural scaffold for cellular growth, promote angiogenesis, and have an anti-inflammatory effect. For the practitioner, this means the product works to repair the skin's biological environment and improve tissue quality from a cellular level, rather than by adding mechanical volume.

Sculptra and Juvelook are based on Poly-L-Lactic Acid (PLLA), a biocompatible and biodegradable synthetic polymer. PLLA's primary function is to act as a powerful collagen stimulator. When injected, the PLLA microparticles trigger a controlled inflammatory response that leads to neocollagenesis—the body's production of new collagen fibers. This process gradually restores volume and structural integrity to the treated area. The key difference is that PLLA products build structure over time, with effects becoming apparent several weeks to months after treatment as new collagen forms. Sourcing an established PLLA product like Sculptra (2 vials) provides clinics with a globally recognized brand for volumization.

The choice of which product to stock directly influences the types of treatments a clinic can offer.

Stocking Rejuran Healer is suitable for clinics focusing on skin quality, texture, and overall rejuvenation. Its primary applications include:

• Improving the appearance of fine lines, especially in delicate areas like the periorbital and perioral regions.
• Reducing the appearance of enlarged pores.
• Addressing atrophic acne scarring.
• Enhancing overall skin hydration, tone, and elasticity. It is often positioned as a 'skin repair' treatment, appealing to a wide demographic, including younger patients seeking preventative care or 'prejuvenation'. A similar focus on the eye area is seen with PN products like AMI Eyes.

Stocking Sculptra or Juvelook caters to patients with concerns related to volume loss and skin laxity. These PLLA stimulators are indicated for:

• Correcting deep facial folds, such as nasolabial folds and marionette lines.
• Restoring volume in hollowed areas like the temples and cheeks.
• Improving facial contours and providing structural support. These treatments are typically offered to patients exhibiting moderate to severe signs of aging who require more than just surface-level skin improvement. Offering PLLA allows a clinic to provide non-surgical facial contouring and structural rejuvenation.

Operational efficiency and practitioner training are key factors when adding a new product. These biostimulators have distinct handling requirements.

Rejuran Healer offers simplicity in preparation. It comes in a pre-filled 2mL syringe, eliminating the need for reconstitution. The product can be administered using a fine needle for a series of micro-injections into the superficial dermis. A typical protocol involves 3-4 sessions spaced 2-4 weeks apart.

Sculptra requires a specific and careful reconstitution process. It is supplied as a lyophilized powder in a vial that must be mixed with sterile water for injection (SWFI) several hours, or even a day, before the treatment to ensure full hydration of the PLLA particles. Improper reconstitution can affect product performance and safety. Practitioners must be trained on the correct dilution and injection techniques. Post-treatment massage by the patient is also a mandatory part of the protocol.

Juvelook also requires reconstitution. Its formulation, which often combines PDLLA with non-cross-linked hyaluronic acid, is designed to reduce the waiting time for particle hydration compared to traditional PLLA. The HA component provides some immediate hydration, which can be a selling point for some clinics. However, the fundamental requirement for mixing remains a key difference from ready-to-use PN products.

The optimal inventory for a clinic depends on its patient demographics, practitioner expertise, and business model. It is often beneficial to offer treatments from different categories to serve a wider range of needs.

Stock Rejuran Healer if your clinic:

• Has a strong focus on skin health, 'glass skin' trends, and regenerative aesthetics.
• Serves a younger demographic interested in preventative treatments.
• Prefers products that are ready-to-use with minimal preparation time.
• Wants to offer a solution for fine lines and textural issues that dermal fillers may not be ideal for.

Stock Sculptra or Juvelook if your clinic:

• Specializes in facial contouring, volumization, and advanced anti-aging treatments.
• Has practitioners experienced with reconstitution protocols and deep injection techniques.
• Serves patients with significant volume loss who require structural, long-term collagen stimulation.
• Operates in a market where brand recognition (Sculptra) or innovative Korean technologies (Juvelook) are strong draws.

Ultimately, a comprehensive Skinbooster / biostimulator catalog that includes both PN and PLLA options provides the greatest versatility. It allows practitioners to create combination treatment plans, using PLLA for foundational support and PN for refining superficial skin quality. This tiered approach can enhance clinical outcomes and business growth. For more on sourcing established brands, see our professional guide on Radiesse 0.8.